

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 8.05427895 |
| 2 | cytidine metabolic process (GO:0046087) | 7.82194750 |
| 3 | cytidine catabolic process (GO:0006216) | 7.82194750 |
| 4 | cytidine deamination (GO:0009972) | 7.82194750 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.05111217 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.96874929 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 5.88002779 |
| 8 | leukocyte aggregation (GO:0070486) | 5.56910727 |
| 9 | activation of MAPKKK activity (GO:0000185) | 5.55764945 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.80429644 |
| 11 | chaperone-mediated protein transport (GO:0072321) | 4.64231225 |
| 12 | viral transcription (GO:0019083) | 4.61727879 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 4.60681033 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.60681033 |
| 15 | translational termination (GO:0006415) | 4.40466861 |
| 16 | regulation of activation of Janus kinase activity (GO:0010533) | 4.39880281 |
| 17 | macrophage chemotaxis (GO:0048246) | 4.36315855 |
| 18 | positive regulation of defense response to virus by host (GO:0002230) | 4.36194417 |
| 19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.30261630 |
| 20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.27373069 |
| 21 | metallo-sulfur cluster assembly (GO:0031163) | 4.21145042 |
| 22 | iron-sulfur cluster assembly (GO:0016226) | 4.21145042 |
| 23 | negative regulation by host of viral transcription (GO:0043922) | 4.21100019 |
| 24 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.20003622 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 4.01973799 |
| 26 | translational elongation (GO:0006414) | 3.97459653 |
| 27 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.87779358 |
| 28 | protein targeting to ER (GO:0045047) | 3.85888469 |
| 29 | cotranslational protein targeting to membrane (GO:0006613) | 3.85658759 |
| 30 | eosinophil chemotaxis (GO:0048245) | 3.81751613 |
| 31 | respiratory electron transport chain (GO:0022904) | 3.71213636 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.69796844 |
| 33 | protein localization to endoplasmic reticulum (GO:0070972) | 3.67738355 |
| 34 | electron transport chain (GO:0022900) | 3.66882805 |
| 35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.63271252 |
| 36 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.61321200 |
| 37 | sequestering of actin monomers (GO:0042989) | 3.55330401 |
| 38 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.55063245 |
| 39 | eosinophil migration (GO:0072677) | 3.48204051 |
| 40 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.45325042 |
| 41 | regulation of regulatory T cell differentiation (GO:0045589) | 3.45237451 |
| 42 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.45038228 |
| 43 | behavioral response to nicotine (GO:0035095) | 3.39685977 |
| 44 | positive T cell selection (GO:0043368) | 3.39092543 |
| 45 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.35651019 |
| 46 | positive regulation of T cell apoptotic process (GO:0070234) | 3.33032778 |
| 47 | protein neddylation (GO:0045116) | 3.32298408 |
| 48 | cellular protein complex disassembly (GO:0043624) | 3.26053532 |
| 49 | viral life cycle (GO:0019058) | 3.25559379 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.18829796 |
| 51 | cytolysis (GO:0019835) | 3.17757172 |
| 52 | glycoprotein catabolic process (GO:0006516) | 3.17662593 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.15580865 |
| 54 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.13412776 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.09231942 |
| 56 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.08744217 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03438755 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03438755 |
| 59 | negative regulation of viral genome replication (GO:0045071) | 3.02613865 |
| 60 | negative regulation of T cell apoptotic process (GO:0070233) | 2.99591960 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96286308 |
| 62 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93409897 |
| 63 | male meiosis I (GO:0007141) | 2.91635985 |
| 64 | protein complex biogenesis (GO:0070271) | 2.90859144 |
| 65 | rRNA transcription (GO:0009303) | 2.89669417 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 2.89110045 |
| 67 | regulation of interleukin-8 secretion (GO:2000482) | 2.85516049 |
| 68 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.84524895 |
| 69 | positive regulation of translational initiation (GO:0045948) | 2.84032525 |
| 70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83042394 |
| 71 | T cell migration (GO:0072678) | 2.76884692 |
| 72 | positive regulation of cell killing (GO:0031343) | 2.75907626 |
| 73 | translation (GO:0006412) | 2.74975208 |
| 74 | translational initiation (GO:0006413) | 2.73912760 |
| 75 | actin nucleation (GO:0045010) | 2.72084363 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71303742 |
| 77 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.71301227 |
| 78 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.68938466 |
| 79 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.67229663 |
| 80 | NADH dehydrogenase complex assembly (GO:0010257) | 2.67229663 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.67229663 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66838927 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.66285862 |
| 84 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.65863978 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64921286 |
| 86 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.64365673 |
| 87 | endoderm formation (GO:0001706) | 2.60103931 |
| 88 | detection of light stimulus involved in visual perception (GO:0050908) | 2.60054790 |
| 89 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.60054790 |
| 90 | protein complex disassembly (GO:0043241) | 2.59452888 |
| 91 | response to interferon-beta (GO:0035456) | 2.59163665 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.58618493 |
| 93 | hydrogen ion transmembrane transport (GO:1902600) | 2.57695106 |
| 94 | regulation of lymphocyte migration (GO:2000401) | 2.56794273 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.56267530 |
| 96 | ncRNA 3-end processing (GO:0043628) | 2.55719936 |
| 97 | transmission of nerve impulse (GO:0019226) | 2.55506737 |
| 98 | proton transport (GO:0015992) | 2.54000398 |
| 99 | positive regulation of T cell chemotaxis (GO:0010820) | 2.53918835 |
| 100 | regulation of T cell chemotaxis (GO:0010819) | 2.53918835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.30572533 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.32634398 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.24222008 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.11979151 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90666266 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71922034 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.48054161 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47661417 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.47050140 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.26816787 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.16835944 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07043502 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01995676 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00239435 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.87619441 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84999525 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82852733 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.79585414 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.77591790 |
| 20 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.77042069 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75516063 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72966208 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.65575934 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.64256596 |
| 25 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.61695775 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59745697 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59357572 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51927893 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49995730 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46169827 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46087963 |
| 32 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.41051970 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40313746 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40021410 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39224553 |
| 36 | AR_20517297_ChIP-Seq_VCAP_Human | 1.36885862 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35440336 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35196582 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33937536 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.32854799 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32417353 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.31515513 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.30807583 |
| 44 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.30667959 |
| 45 | ERA_21632823_ChIP-Seq_H3396_Human | 1.30599397 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30558919 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29686808 |
| 48 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29384323 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29221712 |
| 50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28489593 |
| 51 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27744325 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27724047 |
| 53 | NCOR_22424771_ChIP-Seq_293T_Human | 1.27444239 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26952688 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26844524 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26289999 |
| 57 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.24821075 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.24095742 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23264698 |
| 60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19471226 |
| 61 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19334715 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.18669767 |
| 63 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18200256 |
| 64 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18065627 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16622136 |
| 66 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.16230226 |
| 67 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15713615 |
| 68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15576392 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15507444 |
| 70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14576562 |
| 71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12796447 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11226487 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09205826 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08212665 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06314087 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06314087 |
| 77 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06144102 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05821880 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.05702445 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05085749 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04352395 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02846286 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02427174 |
| 84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02315047 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01797268 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01772311 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01436398 |
| 88 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.99825354 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99117101 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.98897027 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98202521 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95828602 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95573445 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95154878 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94878808 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94723136 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.94151840 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93762830 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93058679 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92599748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.98587158 |
| 2 | MP0005623_abnormal_meninges_morphology | 4.59883969 |
| 3 | MP0001348_abnormal_lacrimal_gland | 4.14216852 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.13653830 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 2.95853975 |
| 6 | MP0003878_abnormal_ear_physiology | 2.95853975 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.46017621 |
| 8 | MP0004147_increased_porphyrin_level | 2.27380725 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.09199808 |
| 10 | MP0002163_abnormal_gland_morphology | 2.05327179 |
| 11 | MP0003136_yellow_coat_color | 1.99204373 |
| 12 | MP0003786_premature_aging | 1.96994702 |
| 13 | MP0002638_abnormal_pupillary_reflex | 1.93069792 |
| 14 | MP0003011_delayed_dark_adaptation | 1.89210296 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.89026363 |
| 16 | MP0009785_altered_susceptibility_to | 1.88676278 |
| 17 | MP0006292_abnormal_olfactory_placode | 1.88385767 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 1.79832390 |
| 19 | MP0000750_abnormal_muscle_regeneration | 1.79515896 |
| 20 | MP0001800_abnormal_humoral_immune | 1.73850294 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 1.70463448 |
| 22 | MP0001790_abnormal_immune_system | 1.65503230 |
| 23 | MP0005387_immune_system_phenotype | 1.65503230 |
| 24 | MP0001873_stomach_inflammation | 1.65338172 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.59519534 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.58841924 |
| 27 | MP0002102_abnormal_ear_morphology | 1.58264760 |
| 28 | MP0004885_abnormal_endolymph | 1.54851629 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.51316206 |
| 30 | MP0003646_muscle_fatigue | 1.45021698 |
| 31 | MP0001188_hyperpigmentation | 1.44418917 |
| 32 | MP0008872_abnormal_physiological_respon | 1.44381942 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.43738785 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.42659088 |
| 35 | MP0002723_abnormal_immune_serum | 1.41413898 |
| 36 | MP0006082_CNS_inflammation | 1.39680938 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.38824960 |
| 38 | MP0002938_white_spotting | 1.37556529 |
| 39 | MP0000685_abnormal_immune_system | 1.37504413 |
| 40 | MP0009384_cardiac_valve_regurgitation | 1.37390902 |
| 41 | MP0005025_abnormal_response_to | 1.37058156 |
| 42 | MP0001819_abnormal_immune_cell | 1.36463306 |
| 43 | MP0003866_abnormal_defecation | 1.31086969 |
| 44 | MP0001905_abnormal_dopamine_level | 1.29008083 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.26890055 |
| 46 | MP0002095_abnormal_skin_pigmentation | 1.25985445 |
| 47 | MP0003137_abnormal_impulse_conducting | 1.25948295 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24980280 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.24010750 |
| 50 | MP0003195_calcinosis | 1.18566207 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.17708379 |
| 52 | MP0004742_abnormal_vestibular_system | 1.17035424 |
| 53 | MP0004142_abnormal_muscle_tone | 1.16217555 |
| 54 | MP0000858_altered_metastatic_potential | 1.14743666 |
| 55 | MP0005389_reproductive_system_phenotype | 1.14729482 |
| 56 | MP0002933_joint_inflammation | 1.11769472 |
| 57 | MP0002160_abnormal_reproductive_system | 1.10458490 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.09215139 |
| 59 | MP0004130_abnormal_muscle_cell | 1.03352081 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.02775051 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.02091360 |
| 62 | MP0009745_abnormal_behavioral_response | 0.99660323 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 0.98982954 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 0.92451143 |
| 65 | MP0005253_abnormal_eye_physiology | 0.92273619 |
| 66 | MP0005083_abnormal_biliary_tract | 0.92011712 |
| 67 | MP0001919_abnormal_reproductive_system | 0.91218435 |
| 68 | MP0000716_abnormal_immune_system | 0.91187921 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90153457 |
| 70 | MP0002067_abnormal_sensory_capabilities | 0.88375313 |
| 71 | MP0009764_decreased_sensitivity_to | 0.86902346 |
| 72 | MP0003880_abnormal_central_pattern | 0.86600863 |
| 73 | MP0008877_abnormal_DNA_methylation | 0.85755154 |
| 74 | MP0002736_abnormal_nociception_after | 0.83086043 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.82739183 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.81168059 |
| 77 | MP0005646_abnormal_pituitary_gland | 0.79689329 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.78756527 |
| 79 | MP0005410_abnormal_fertilization | 0.78346391 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.77450256 |
| 81 | MP0003879_abnormal_hair_cell | 0.76932934 |
| 82 | MP0001970_abnormal_pain_threshold | 0.76579226 |
| 83 | MP0000762_abnormal_tongue_morphology | 0.76396089 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75778790 |
| 85 | MP0002733_abnormal_thermal_nociception | 0.75496552 |
| 86 | MP0005195_abnormal_posterior_eye | 0.72530885 |
| 87 | MP0001293_anophthalmia | 0.72257874 |
| 88 | MP0002722_abnormal_immune_system | 0.72256406 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.72256008 |
| 90 | MP0002405_respiratory_system_inflammati | 0.72138813 |
| 91 | MP0001529_abnormal_vocalization | 0.71980795 |
| 92 | MP0002272_abnormal_nervous_system | 0.71479907 |
| 93 | MP0010307_abnormal_tumor_latency | 0.71468588 |
| 94 | MP0002177_abnormal_outer_ear | 0.71275381 |
| 95 | MP0003936_abnormal_reproductive_system | 0.70437551 |
| 96 | MP0002398_abnormal_bone_marrow | 0.70313305 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.70295096 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.70173980 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.68568250 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.68551485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type II lissencephaly (HP:0007260) | 6.17201709 |
| 2 | Retinal atrophy (HP:0001105) | 6.16242377 |
| 3 | Cerebellar dysplasia (HP:0007033) | 6.10790343 |
| 4 | Retinal dysplasia (HP:0007973) | 5.86571443 |
| 5 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 5.23628908 |
| 6 | Hypoplasia of the pons (HP:0012110) | 5.21295726 |
| 7 | Abnormality of the pons (HP:0007361) | 4.87009766 |
| 8 | Abolished electroretinogram (ERG) (HP:0000550) | 4.43317468 |
| 9 | IgG deficiency (HP:0004315) | 4.03141380 |
| 10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.95865305 |
| 11 | Increased IgM level (HP:0003496) | 3.86292813 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.43216073 |
| 13 | Fatigue (HP:0012378) | 3.28321331 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.28015841 |
| 15 | T lymphocytopenia (HP:0005403) | 3.27099338 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09169994 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.09142846 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.06755866 |
| 19 | Severe muscular hypotonia (HP:0006829) | 2.88325957 |
| 20 | Recurrent bronchitis (HP:0002837) | 2.87195571 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 2.86801801 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 2.86801801 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80535769 |
| 24 | Difficulty climbing stairs (HP:0003551) | 2.80531869 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73886938 |
| 26 | Progressive macrocephaly (HP:0004481) | 2.73433308 |
| 27 | Buphthalmos (HP:0000557) | 2.72930081 |
| 28 | Acute encephalopathy (HP:0006846) | 2.72173776 |
| 29 | Aplastic anemia (HP:0001915) | 2.69976944 |
| 30 | Hypoalbuminemia (HP:0003073) | 2.64477149 |
| 31 | Abnormal albumin level (HP:0012116) | 2.64477149 |
| 32 | Pallor (HP:0000980) | 2.64305359 |
| 33 | Increased CSF lactate (HP:0002490) | 2.62825441 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.61085500 |
| 35 | Abnormality of DNA repair (HP:0003254) | 2.59663451 |
| 36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53811927 |
| 37 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53811927 |
| 38 | Hepatocellular necrosis (HP:0001404) | 2.49663551 |
| 39 | Entropion (HP:0000621) | 2.44632911 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.41958362 |
| 41 | Pancreatic cysts (HP:0001737) | 2.40147082 |
| 42 | Hypoproteinemia (HP:0003075) | 2.36906905 |
| 43 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.33866371 |
| 44 | Colon cancer (HP:0003003) | 2.31762523 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.31714765 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.23320125 |
| 47 | Chronic otitis media (HP:0000389) | 2.23287908 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.22181747 |
| 49 | Abnormality of T cells (HP:0002843) | 2.19720105 |
| 50 | Chronic sinusitis (HP:0011109) | 2.15355772 |
| 51 | Eosinophilia (HP:0001880) | 2.15338526 |
| 52 | True hermaphroditism (HP:0010459) | 2.15008442 |
| 53 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.14637666 |
| 54 | Nasal polyposis (HP:0100582) | 2.09924653 |
| 55 | Cerebral edema (HP:0002181) | 2.09617952 |
| 56 | Lissencephaly (HP:0001339) | 2.09173377 |
| 57 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09061781 |
| 58 | Hepatic necrosis (HP:0002605) | 2.08912519 |
| 59 | Sclerocornea (HP:0000647) | 2.07987171 |
| 60 | Bronchitis (HP:0012387) | 2.07680650 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.05797550 |
| 62 | Reticulocytopenia (HP:0001896) | 2.05420286 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.01631112 |
| 64 | Rectal prolapse (HP:0002035) | 1.96536976 |
| 65 | Generalized muscle weakness (HP:0003324) | 1.96263610 |
| 66 | Decreased central vision (HP:0007663) | 1.95917465 |
| 67 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.95751524 |
| 68 | Nephronophthisis (HP:0000090) | 1.95673963 |
| 69 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.95552344 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 1.94160372 |
| 71 | Abnormal drinking behavior (HP:0030082) | 1.90848109 |
| 72 | Polydipsia (HP:0001959) | 1.90848109 |
| 73 | Severe visual impairment (HP:0001141) | 1.89409733 |
| 74 | Erythroderma (HP:0001019) | 1.86593482 |
| 75 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.83311585 |
| 76 | Hypoplasia of the brainstem (HP:0002365) | 1.83311585 |
| 77 | Renal Fanconi syndrome (HP:0001994) | 1.81232797 |
| 78 | Hypothermia (HP:0002045) | 1.81201926 |
| 79 | Cellular immunodeficiency (HP:0005374) | 1.80360675 |
| 80 | Optic disc pallor (HP:0000543) | 1.79697760 |
| 81 | Leukocytosis (HP:0001974) | 1.78970716 |
| 82 | Pachygyria (HP:0001302) | 1.77209445 |
| 83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76566590 |
| 84 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76177045 |
| 85 | Lethargy (HP:0001254) | 1.74953429 |
| 86 | Obstructive lung disease (HP:0006536) | 1.73526495 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73526495 |
| 88 | Methylmalonic acidemia (HP:0002912) | 1.70971714 |
| 89 | Abnormality of magnesium homeostasis (HP:0004921) | 1.70883940 |
| 90 | Encephalitis (HP:0002383) | 1.70801562 |
| 91 | Poikiloderma (HP:0001029) | 1.70666707 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 1.70034325 |
| 93 | Megalocornea (HP:0000485) | 1.69852523 |
| 94 | Abnormal number of erythroid precursors (HP:0012131) | 1.66897646 |
| 95 | Keratitis (HP:0000491) | 1.65304108 |
| 96 | Gastrointestinal infarctions (HP:0005244) | 1.64374947 |
| 97 | Methylmalonic aciduria (HP:0012120) | 1.64052202 |
| 98 | Abnormality of the vitreous humor (HP:0004327) | 1.63037071 |
| 99 | Rib fusion (HP:0000902) | 1.62279455 |
| 100 | Polyuria (HP:0000103) | 1.61380197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.51656390 |
| 2 | MAP3K13 | 4.33725666 |
| 3 | KDR | 3.67142388 |
| 4 | MARK3 | 3.41776097 |
| 5 | STK10 | 3.14547600 |
| 6 | TESK2 | 3.07936355 |
| 7 | BCKDK | 2.97739328 |
| 8 | TAOK3 | 2.96150982 |
| 9 | STK16 | 2.67685827 |
| 10 | WNK4 | 2.64532584 |
| 11 | ADRBK2 | 2.37699423 |
| 12 | MAP3K9 | 2.29714204 |
| 13 | MAP4K1 | 2.20139429 |
| 14 | ARAF | 2.19221119 |
| 15 | TLK1 | 1.86780078 |
| 16 | GRK1 | 1.84246782 |
| 17 | PINK1 | 1.76456227 |
| 18 | ITK | 1.53839530 |
| 19 | PIM1 | 1.50322207 |
| 20 | PRKCQ | 1.33410503 |
| 21 | PDK2 | 1.23354392 |
| 22 | STK11 | 1.23208969 |
| 23 | MAP3K11 | 1.19164265 |
| 24 | MUSK | 1.14408380 |
| 25 | TIE1 | 1.08539189 |
| 26 | PTK2B | 1.01660407 |
| 27 | MAP4K2 | 0.99903801 |
| 28 | FRK | 0.96492197 |
| 29 | BRAF | 0.94001866 |
| 30 | SYK | 0.93719376 |
| 31 | GRK7 | 0.91232995 |
| 32 | LCK | 0.91147587 |
| 33 | MAP2K7 | 0.88162840 |
| 34 | BMPR1B | 0.86488646 |
| 35 | LIMK1 | 0.85623814 |
| 36 | PRKCH | 0.83802645 |
| 37 | TNK2 | 0.81555483 |
| 38 | CAMKK2 | 0.78225468 |
| 39 | STK39 | 0.74761278 |
| 40 | FES | 0.74442375 |
| 41 | TEC | 0.73516161 |
| 42 | ILK | 0.73406436 |
| 43 | BTK | 0.73009093 |
| 44 | MOS | 0.72819142 |
| 45 | PASK | 0.71797285 |
| 46 | PIK3CA | 0.71493046 |
| 47 | ZAK | 0.67605844 |
| 48 | CSK | 0.65138333 |
| 49 | DYRK2 | 0.64301244 |
| 50 | IKBKB | 0.63980887 |
| 51 | INSRR | 0.62968996 |
| 52 | RPS6KA5 | 0.61475317 |
| 53 | MAPK15 | 0.60674174 |
| 54 | LMTK2 | 0.57910173 |
| 55 | NTRK2 | 0.56929421 |
| 56 | GRK6 | 0.56633421 |
| 57 | CLK1 | 0.55355939 |
| 58 | CAMKK1 | 0.54584199 |
| 59 | OBSCN | 0.53788967 |
| 60 | MAPKAPK3 | 0.53381844 |
| 61 | NUAK1 | 0.51546685 |
| 62 | VRK2 | 0.50725767 |
| 63 | VRK1 | 0.49404895 |
| 64 | MAPK13 | 0.48708598 |
| 65 | FYN | 0.46654075 |
| 66 | AURKA | 0.46402858 |
| 67 | CAMK1 | 0.45773536 |
| 68 | PRKACA | 0.44536763 |
| 69 | LYN | 0.43792839 |
| 70 | OXSR1 | 0.43005749 |
| 71 | MYLK | 0.40280727 |
| 72 | PLK4 | 0.39664266 |
| 73 | PRKCA | 0.39053439 |
| 74 | IGF1R | 0.38674544 |
| 75 | MATK | 0.38647756 |
| 76 | PRKCG | 0.38379674 |
| 77 | WNK3 | 0.37869600 |
| 78 | CSNK1A1 | 0.36197328 |
| 79 | NME1 | 0.36046203 |
| 80 | TYRO3 | 0.34435069 |
| 81 | ADRBK1 | 0.34351370 |
| 82 | NLK | 0.33910224 |
| 83 | CDK19 | 0.33213512 |
| 84 | PIK3CG | 0.31909520 |
| 85 | CSNK2A2 | 0.31780370 |
| 86 | CAMK2A | 0.30502956 |
| 87 | NTRK1 | 0.29456363 |
| 88 | RAF1 | 0.27053637 |
| 89 | ZAP70 | 0.26556221 |
| 90 | MAP3K12 | 0.26156848 |
| 91 | MAP3K4 | 0.26039246 |
| 92 | CSNK2A1 | 0.25834767 |
| 93 | MAP2K6 | 0.25084206 |
| 94 | CSF1R | 0.24234612 |
| 95 | INSR | 0.23408159 |
| 96 | PRKCD | 0.22803458 |
| 97 | ROCK1 | 0.22751245 |
| 98 | SGK1 | 0.20919856 |
| 99 | PIM2 | 0.18982723 |
| 100 | BRSK2 | 0.18508810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.41256925 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.01397497 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.99032242 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.43087312 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.30364043 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.59375563 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58042949 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.48368988 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.41311825 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.35439626 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.34129501 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20105227 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.11696503 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.11582774 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09800323 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.95146893 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79906271 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.79542278 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75628005 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74977601 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64716333 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63275789 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60167856 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57715322 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46324693 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45227895 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42893363 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.39649681 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.37988384 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.37693917 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.33946912 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29256940 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28957644 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24220539 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20155478 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07671557 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04108605 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02357753 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01499000 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99733911 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97599308 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96808813 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91683117 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86698695 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81424626 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78959169 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75139959 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74468749 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72743209 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.67452236 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64512858 |
| 52 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63509278 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61528623 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60580429 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60303809 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.58728639 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58702449 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57565163 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54818599 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53506600 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.49469045 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47706728 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47265717 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47217843 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45552290 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45493423 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.43590404 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43502728 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43019007 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.42356156 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.41060729 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.40788076 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39311195 |
| 74 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37833674 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36643610 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36205689 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34649926 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33754177 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32961912 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32824133 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.32431312 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31757849 |
| 83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.30318851 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.29997554 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27982429 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26434523 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25870395 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24186340 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.23671135 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21874095 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18895610 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18544893 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.18367282 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.18323705 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18106354 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17815343 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16792507 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16615894 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16594913 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16320987 |

